Baxion
ScreeningTagsAlerts

First Tracks Biotherapeutics, Inc.

TRAX·NASDAQ·$17.06Share Price as of 11/2·$595MMarket Cap as of 11/2

Financials

10-QQuarter ended 06/30/2608/12/2610-QQuarter ended 03/31/2605/14/26

Disclosures

8-KCurrent report10/20/268-KCurrent report10/15/268-KCurrent report10/13/268-KCurrent report08/12/268-KCurrent report06/22/26

Prospectuses and Registrations

S-1Registration statement (IPO)10/26/26424B3Prospectus08/13/26424B3Prospectus05/15/26424B3Prospectus05/14/26S-1Registration statement (IPO)05/08/26

Proxies

No matching filings.

Ownership

Form 4Insider transaction09/17/26Form 4Insider transaction09/04/26144Proposed sale of securities09/02/26Form 4Insider transaction08/18/26Form 4Insider transaction08/18/26

Other

EFFECTRequest for effectiveness10/29/26EFFECTRequest for effectiveness05/12/26CORRESPCorrespondence with the SEC05/08/26UPLOADLetter from the SEC05/06/26DRSDRS05/01/26

Latest Filings

EFFECTRequest for effectiveness10/29/26S-1Registration statement (IPO)10/26/268-KCurrent report10/20/268-KCurrent report10/15/268-KCurrent report10/13/26

Ownership

Form 4Insider transaction09/17/26Form 4Insider transaction09/04/26144Proposed sale of securities09/02/26Form 4Insider transaction08/18/26Form 4Insider transaction08/18/26
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact